| Literature DB >> 29137247 |
Wei Sun1, Zeting Qiu2, Wulin Tan2, Zhongqi Liu1, Zhongxing Wang2, Wenqi Huang2, Minghui Cao1.
Abstract
Marital status was found to be an independent prognostic factor for survival in several cancers. However related researches of oral tongue squamous cell carcinoma (OTSCC) are still rare. We explored the Surveillance, Epidemiology, and End Results (SEER) program and finally identified 14,194 patients with OTSCC. Kaplan-Meier analysis and multivariate Cox regression models were used to distinguish risk factors for overall survival (OS) and tumor cause-specific survival (TCSS). Widowed patients had the highest percentage of female, highest average ages and more prevalence with localized SEER Stage significantly, while patients in the single group were younger than other groups. After univariate analysis and multivariate analysis, marital status was demonstrated to be an independent prognostic factor of OS and TCSS. Married patients showed better 5-year OS (65.6%) and 5-year TCSS (89.9%) than other patients. Subgroup survival analysis according to AJCC TNM stage and SEER stage showed that the widowed patients demonstrated worst OS and TCSS compared to other groups. Marital status was an important prognostic factor for survival in patients with OTSCC. Widowed patients exhibited with the highest risk of death compared with other groups.Entities:
Keywords: SEER; biopsychosocial medical model; marital status; oral tongue squamous cell carcinoma; survival analysis
Year: 2017 PMID: 29137247 PMCID: PMC5669873 DOI: 10.18632/oncotarget.18538
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Baseline characteristic of patients with oral tongue squamous cell carcinoma in SEER database
| Characteristic | Total | Married | Single | Divorced/Separated | Widowed | ||
|---|---|---|---|---|---|---|---|
| (%) | (%) | (%) | (%) | ||||
| 14194 (100.0) | 8298 (58.5) | 2705 (19.1) | 2001 (14.1) | 1190 (8.4) | |||
| Gender | < 0.001 | ||||||
| Male | 10137 (71.4) | 6294 (75.8) | 1994 (73.7) | 1459 (72.9) | 390 (32.8) | ||
| Female | 4057 (28.6) | 2004 (24.2) | 711 (26.3) | 542 (27.1) | 800 (67.2) | ||
| Age | < 0.001 | ||||||
| 60.2 ± 12.5 | 60.0 ± 12.1 | 54.9 ± 12.8 | 60.1 ± 10.1 | 74.0 ± 11.1 | |||
| Race | < 0.001 | ||||||
| White | 12218 (86.1) | 7343 (88.5) | 2149 (79.4) | 1744 (87.2) | 982 (82.5) | ||
| Black | 1059 (7.5) | 328 (4.0) | 436 (16.1) | 180 (9.0) | 115 (9.7) | ||
| Others | 917 (6.5) | 627 (7.6) | 120 (4.4) | 77 (3.8) | 93 (7.8) | ||
| Grade | < 0.001 | ||||||
| I | 2108 (14.9) | 1247 (15.0) | 388 (14.3) | 264 (13.2) | 209 (17.6) | ||
| II | 6999 (49.3) | 3953 (47.6) | 1420 (52.5) | 995 (49.7) | 631 (53.0) | ||
| III | 4967 (35.0) | 3018 (36.4) | 882 (32.6) | 720 (36.0) | 347 (29.2) | ||
| IV | 120 (0.8) | 80 (1.0) | 15 (0.6) | 22 (1.1) | 3 (0.3) | ||
| AJCC stage | < 0.001 | ||||||
| I | 3183 (22.4) | 2035 (24.5) | 520 (19.2) | 313 (15.6) | 315 (26.5) | ||
| II | 1672 (11.8) | 942 (11.4) | 294 (10.9) | 234 (11.7) | 202 (17.0) | ||
| III | 2392 (16.9) | 1395 (16.8) | 471 (17.4) | 319 (15.9) | 207 (17.4) | ||
| IV | 6947 (48.9) | 3926 (47.3) | 1420 (52.5) | 1135 (56.7) | 466 (39.2) | ||
| SEER stage | < 0.001 | ||||||
| Localized | 4345 (30.6) | 2678 (32.3) | 742 (27.4) | 461 (23.0) | 464 (39.0) | ||
| Regional | 7316 (51.5) | 4376 (52.7) | 1359 (50.2) | 1072 (53.6) | 509 (42.8) | ||
| Distant | 2533 (17.8) | 1244 (15.0) | 604 (22.3) | 468 (23.4) | 217 (18.2) | ||
| Surgery | < 0.001 | ||||||
| Yes | 8000 (56.4) | 4821 (58.1) | 1491 (55.1) | 981 (49.0) | 707 (59.4) | ||
| No | 6194 (43.6) | 3477 (41.9) | 1214 (44.9) | 1020 (51.0) | 483 (40.6) | ||
| Radiation | < 0.001 | ||||||
| Yes | 6021 (42.4) | 3411 (41.1) | 1165 (43.1) | 986 (49.3) | 459 (38.6) | ||
| No | 8173 (57.6) | 4887 (58.9) | 1540 (56.9) | 1015 (50.7) | 731 (61.4) | ||
Notes: AJCC, the American Joint Committee on Cancer; SEER, the Surveillance, Epidemiology and End Results.
Univariate and multivariate analysis for overall survival
| Characteristic | 5-year OS | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|---|
| Log Rank | HR | 95% CI | |||||
| χ2 test | |||||||
| Gender | |||||||
| Male | 58.1% | 0.9 | 0.330 | ||||
| Female | 57.0% | ||||||
| Age | < 0.001 | ||||||
| < 60 | 64.8% | 285 | < 0.001 | Reference | |||
| ≥ 60 | 50.8% | 1.617 | 1.526–1.713 | < 0.001 | |||
| Race | < 0.001 | ||||||
| White | 59.4% | 244 | < 0.001 | Reference | |||
| Black | 37.3% | 1.495 | 1.368–1.634 | < 0.001 | |||
| Others | 60.0% | 1.125 | 1.003–1.263 | 0.045 | |||
| Marital Status | < 0.001 | ||||||
| Married | 65.6% | 569 | < 0.001 | Reference | |||
| Single | 49.3% | 1.645 | 1.531–1.767 | < 0.001 | |||
| Divorced/Separated | 49.1% | 1.517 | 1.404–1.638 | < 0.001 | |||
| Widowed | 37.5% | 1.999 | 1.829–2.185 | < 0.001 | |||
| Grade | < 0.001 | ||||||
| I | 64.2% | 42.9 | < 0.001 | Reference | |||
| II | 55.5% | 0.990 | 0.906–1.081 | 0.819 | |||
| III | 58.3% | 0.803 | 0.729–0.884 | < 0.001 | |||
| IV | 62.3% | 0.752 | 0.547–1.033 | 0.079 | |||
| AJCC stage | 596 | < 0.001 | < 0.001 | ||||
| I | 74.9% | Reference | |||||
| II | 61.3% | 1.617 | 1.439–1.817 | < 0.001 | |||
| III | 57.0% | 1.814 | 1.552–2.119 | < 0.001 | |||
| IV | 49.2% | 1.974 | 1.686–2.311 | < 0.001 | |||
| SEER stage | 1072 | < 0.001 | < 0.001 | ||||
| Localized | 70.9% | Reference | |||||
| Regional | 58.1% | 1.089 | 0.950–1.248 | 0.220 | |||
| Distant | 34.3% | 2.004 | 1.722–2.332 | < 0.001 | |||
| Surgery | < 0.001 | ||||||
| Yes | 62.8% | 252 | < 0.001 | Reference | |||
| No | 51.3% | 2.416 | 2.010–2.904 | < 0.001 | |||
| Radiation | < 0.001 | ||||||
| Yes | 52.2% | 184 | < 0.001 | Reference | |||
| No | 61.9% | 2.238 | 1.864–2.687 | < 0.001 | |||
Notes: OS, overall survival; HR, hazard ratio; CI, confidence interval; AJCC, the American Joint Committee on Cancer; SEER, the Surveillance, Epidemiology and End Results.
Figure 1Kaplan-Meier survival curves: the overall survival in patients with oral tongue squamous cell carcinoma according to marital status
χ2 = 569, P < 0.001.
Univariate and multivariate analysis for tumor cause-specific survival
| Characteristic | 5-year TCSS | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|---|
| Log Rank | HR | 95% CI | |||||
| χ2 test | |||||||
| Gender | < 0.001 | ||||||
| Male | 86.5% | 4.4 | 0.036 | Reference | |||
| Female | 87.1% | 0.689 | 0.601–0.789 | < 0.001 | |||
| Age | < 0.001 | ||||||
| < 60 | 92.6% | 308 | < 0.001 | Reference | |||
| ≥ 60 | 80.3% | 2.635 | 2.332–2.978 | < 0.001 | |||
| Race | < 0.001 | ||||||
| White | 87.0% | 27.6 | < 0.001 | Reference | |||
| Black | 78.9% | 1.450 | 1.193–1.762 | < 0.001 | |||
| Others | 89.2% | 0.864 | 0.674–1.107 | 0.247 | |||
| Marital Status | < 0.001 | ||||||
| Married | 89.9% | 238 | < 0.001 | Reference | |||
| Single | 85.8% | 1.603 | 1.375–1.869 | < 0.001 | |||
| Divorced/Separated | 81.2% | 1.940 | 1.675–2.247 | < 0.001 | |||
| Widowed | 71.1% | 2.493 | 2.096–2.966 | < 0.001 | |||
| Grade | |||||||
| I | 87.1% | 3.9 | 0.274 | ||||
| II | 85.9% | ||||||
| III | 87.6% | ||||||
| IV | 84.0% | ||||||
| AJCC stage | 17 | < 0.001 | < 0.001 | ||||
| I | 87.9% | Reference | |||||
| II | 84.9% | 1.279 | 1.062–1.540 | 0.009 | |||
| III | 85.6% | 1.211 | 0.925–1.585 | 0.163 | |||
| IV | 87.1% | 0.957 | 0.727–1.258 | 0.751 | |||
| SEER stage | 59.7 | < 0.001 | < 0.001 | ||||
| Localized | 87.1% | Reference | |||||
| Regional | 87.9% | 0.933 | 0.736–1.182 | 0.565 | |||
| Distant | 81.5% | 1.664 | 1.255–2.206 | < 0.001 | |||
| Surgery | 10.9 | < 0.001 | |||||
| Yes | 87.3% | ||||||
| No | 85.9% | ||||||
| Radiation | |||||||
| Yes | 86.2% | 6.1 | 0.014 | ||||
| No | 87.1% | ||||||
Notes: TCSS, tumor cause-specific survival; HR, hazard ratio; CI, confidence interval; AJCC, the American Joint Committee on Cancer; SEER, the Surveillance, Epidemiology and End Results.
Figure 2Kaplan-Meier survival curves: the tumor cause-specific survival in patients with oral tongue squamous cell carcinoma according to marital status
χ2 = 238, P < 0.001.
Multivariate analysis of marital status for overall survival and tumor cause-specific survival
| Variable | Overall survival | Tumor cause-specific survival | |||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | ||||
| Localized | |||||||
| Married | Reference | Reference | |||||
| Single | 1.369 | 1.156–1.621 | < 0.001 | 1.431 | 1.084–1.890 | 0.012 | |
| Divorced/Separated | 1.366 | 1.135–1.644 | < 0.001 | 1.633 | 1.232–2.164 | < 0.001 | |
| Widowed | 1.944 | 1.633–2.315 | < 0.001 | 2.619 | 2.013–3.407 | < 0.001 | |
| Regional | |||||||
| Married | Reference | Reference | |||||
| Single | 1.760 | 1.591–1.946 | < 0.001 | 1.672 | 1.331–2.100 | < 0.001 | |
| Divorced/Separated | 1.518 | 1.362–1.692 | < 0.001 | 2.007 | 1.624–2.480 | < 0.001 | |
| Widowed | 1.977 | 1.723–2.269 | < 0.001 | 2.696 | 2.048–3.550 | < 0.001 | |
| Distant | |||||||
| Married | Reference | Reference | |||||
| Single | 1.545 | 1.355–1.763 | < 0.001 | 1.662 | 1.206–2.290 | 0.002 | |
| Divorced/Separated | 1.506 | 1.311–1.730 | < 0.001 | 2.139 | 1.578–2.900 | < 0.001 | |
| Widowed | 1.710 | 1.420–2.060 | < 0.001 | 1.680 | 1.078–2.618 | 0.022 | |
| I | |||||||
| Married | Reference | Reference | |||||
| Single | 1.207 | 0.964–1.512 | 0.101 | 1.434 | 1.020–2.017 | 0.038 | |
| Divorced/Separated | 1.455 | 1.151–1.841 | 0.002 | 1.641 | 1.157–2.327 | 0.005 | |
| Widowed | 1.778 | 1.422–2.222 | < 0.001 | 2.555 | 1.845–3.538 | < 0.001 | |
| II | |||||||
| Married | Reference | Reference | |||||
| Single | 1.778 | 1.423–2.221 | < 0.001 | 2.045 | 1.371–3.051 | < 0.001 | |
| Divorced/Separated | 1.408 | 1.107–1.792 | 0.005 | 2.112 | 1.454–3.069 | < 0.001 | |
| Widowed | 2.014 | 1.594–2.544 | < 0.001 | 2.383 | 1.567–3.623 | < 0.001 | |
| III | |||||||
| Married | Reference | Reference | |||||
| Single | 1.747 | 1.475–2.070 | < 0.001 | 1.409 | 0.986–2.014 | 0.060 | |
| Divorced/Separated | 1.534 | 1.268–1.856 | < 0.001 | 1.756 | 1.244–2.480 | 0.001 | |
| Widowed | 1.868 | 1.511–2.309 | < 0.001 | 1.959 | 1.308–2.936 | 0.001 | |
| IV | |||||||
| Married | Reference | Reference | |||||
| Single | 1.666 | 1.519–1.827 | < 0.001 | 1.629 | 1.298–2.044 | < 0.001 | |
| Divorced/Separated | 1.541 | 1.397–1.700 | < 0.001 | 2.073 | 1.675–2.564 | < 0.001 | |
| Widowed | 1.976 | 1.733–2.253 | < 0.001 | 2.686 | 2.000–3.607 | < 0.001 | |
Notes: HR, hazard ratio; CI, confidence interval; SEER, the Surveillance, Epidemiology and End Results; AJCC, the American Joint Committee on Cancer.